ciclopirox has been researched along with ketoconazole in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 12 (42.86) | 29.6817 |
| 2010's | 10 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V | 1 |
| Baran, R | 1 |
| Kurata, H; Matsuoka, H; Oh, K; Sumita, O; Takatori, K | 1 |
| Qadripur, SA | 1 |
| Lucky, AW; Ploysangam, T | 1 |
| Orengo, I; Rosen, T; Schell, BJ | 1 |
| Arikian, SR; Doyle, JJ; Einarson, TR; Shear, NH | 1 |
| Goode, K; Squire, RA | 1 |
| Prigent, F | 1 |
| Piérard, GE | 1 |
| Chosidow, O; Dupuy, P; Maurette, C | 1 |
| Gupta, AK; Kohli, Y | 1 |
| Cho, KH; Eun, HC; Lee, HS; Lee, JH | 1 |
| Brousse, S; Panizzutti, C; Roques, C | 1 |
| Kohno, M; Muraoka, W; Nakashima, T; Niwano, Y; Oda, T; Sato, E | 1 |
| Boorman, GC; Ratnavel, RC; Squire, RA | 1 |
| de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA | 1 |
| Cruz, AR; Gallin, JI; Huang, CY; Zarember, KA | 1 |
| Diehl, C; Ferrari, A | 1 |
| Bakhoya, VN; Ojo, OA; Okokon, EO; Ruotsalainen, JH; Verbeek, JH | 1 |
| Chiang, A; Hafeez, F; Hui, X; Kamili, F; Maibach, HI; Zhu, H | 1 |
| Gupta, AK; Versteeg, SG | 1 |
| Eichenfield, LF; Friedlander, SF | 1 |
| Bosshard, PP; Buttafuoco, A; Glatz, M; Leong, C; Schmid, B | 1 |
5 review(s) available for ciclopirox and ketoconazole
| Article | Year |
|---|---|
Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature.
Topics: Allylamine; Antifungal Agents; Child; Child, Preschool; Ciclopirox; Coloring Agents; Female; Foot Dermatoses; Humans; Hydroxides; Imidazoles; Ketoconazole; Male; Mycology; Onychomycosis; Potassium Compounds; Pyridones; Tinea Pedis; Trichophyton | 1997 |
Pharmacoeconomic analysis of topical treatments for tinea infections.
Topics: Administration, Topical; Adult; Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Clotrimazole; Drug Costs; Economics, Pharmaceutical; Humans; Ketoconazole; Pyridones; Tinea; Treatment Outcome | 1995 |
Topical antifungals for seborrhoeic dermatitis.
Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Clotrimazole; Dermatitis, Seborrheic; Facial Dermatoses; Humans; Ketoconazole; Lithium Compounds; Miconazole; Pyridones; Randomized Controlled Trials as Topic; Scalp Dermatoses; Solanum; Steroids | 2015 |
Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antifungal Agents; Calcineurin Inhibitors; Ciclopirox; Dermatitis, Seborrheic; Dermatologic Agents; Desonide; Facial Dermatoses; Humans; Ketoconazole; Malassezia; Mometasone Furoate; Plant Preparations; Practice Guidelines as Topic; Pyridones; Quality of Life; Randomized Controlled Trials as Topic; Tacrolimus; Treatment Outcome; Vitamins | 2017 |
Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; Imidazoles; Incidence; Ketoconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Recurrence; Terbinafine; Tinea Pedis; Treatment Outcome | 2017 |
6 trial(s) available for ciclopirox and ketoconazole
| Article | Year |
|---|---|
Anti-inflammatory activity of antifungal preparations.
Topics: Adult; Allylamine; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Chemoprevention; Ciclopirox; Double-Blind Method; Econazole; Erythema; Female; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Male; Middle Aged; Naphthalenes; Pyridones; Terbinafine; Ultraviolet Rays | 1997 |
A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Antifungal Agents; Child; Ciclopirox; Dermatitis, Seborrheic; Female; Humans; Ketoconazole; Male; Middle Aged; Patient Satisfaction; Pyridones; Safety; Salicylic Acid; Scalp Dermatoses; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome | 2002 |
Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
Topics: Adult; Ciclopirox; Dermatitis, Seborrheic; Dermatologic Agents; Double-Blind Method; Facial Dermatoses; Female; Humans; Ketoconazole; Male; Patient Satisfaction; Pyridones; Treatment Outcome | 2003 |
Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea.
Topics: Administration, Topical; Adolescent; Adult; Ciclopirox; Dermatomycoses; Female; Follow-Up Studies; Hair Preparations; Humans; Ketoconazole; Korea; Male; Middle Aged; Prospective Studies; Pyridones; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2003 |
Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Ciclopirox; Dermatitis, Seborrheic; Double-Blind Method; Hair Preparations; Humans; Ketoconazole; Middle Aged; Pyridones; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2007 |
Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ciclopirox; Dermatitis, Seborrheic; Double-Blind Method; Facial Dermatoses; Female; Gels; Humans; Ketoconazole; Male; Middle Aged; Plant Extracts; Pyridones; Quassia; Young Adult | 2013 |
17 other study(ies) available for ciclopirox and ketoconazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2014 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones | 1992 |
Evaluation of antifungal activity of antimycotics by automatic analyzing system.
Topics: Amphotericin B; Antifungal Agents; Antimycin A; Aspergillus niger; Ciclopirox; Flucytosine; Fungi; Griseofulvin; Image Processing, Computer-Assisted; Ketoconazole; Nystatin; Pyridones; Sodium Chloride | 1992 |
[Antimycotic therapy. 2. Antimycotic chemotherapeutic agents: imidazole derivatives, tolciclate, haloprogin, ciclopiroxolamin].
Topics: Antifungal Agents; Chemical Phenomena; Chemistry; Ciclopirox; Clotrimazole; Dermatomycoses; Econazole; Humans; Imidazoles; Ketoconazole; Miconazole; Phenyl Ethers; Piperazines; Pyridones; Thiocarbamates | 1983 |
[Tinea].
Topics: Adolescent; Age Factors; Alopecia; Antifungal Agents; Child; Ciclopirox; Griseofulvin; Humans; Ketoconazole; Pyridones; Tinea; Tinea Capitis; Tinea Favosa | 2002 |
Seborrheic dermatitis today, gone tomorrow? The link between the biocene and treatment.
Topics: Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Dermatitis, Seborrheic; Dermatomycoses; Humans; Ketoconazole; Malassezia; Pyridones | 2003 |
In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Terbinafine | 2003 |
In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.
Topics: Antifungal Agents; Ciclopirox; Dermatitis, Seborrheic; Drug Therapy, Combination; Hair Preparations; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Organometallic Compounds; Pyridines; Pyridones | 2006 |
Inhibitory or scavenging action of ketoconazole and ciclopiroxolamine against reactive oxygen species released by primed inflammatory cells.
Topics: Animals; Antifungal Agents; Ciclopirox; Dermatitis, Atopic; Drug Combinations; Female; Ketoconazole; Mice; Pyridones; Reactive Oxygen Species; Treatment Outcome; Xanthine Oxidase | 2007 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2007 |
Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Ciclopirox; Deferiprone; Drug Combinations; Fluconazole; Iron Chelating Agents; Ketoconazole; Microbial Sensitivity Tests; Pyridones | 2009 |
Stratum corneum reservoir as a predictive method for in vitro percutaneous absorption.
Topics: Benzylamines; Cadaver; Ciclopirox; Epidermis; Humans; Ketoconazole; Linear Models; Naphthalenes; Pyridones; Skin; Skin Absorption; Terbinafine | 2016 |
In vitro efficacy of antifungal agents alone and in shampoo formulation against dandruff-associated Malassezia spp. and Staphylococcus spp.
Topics: Antifungal Agents; Ciclopirox; Dandruff; Hair Preparations; Humans; In Vitro Techniques; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Organometallic Compounds; Pyridines; Sodium Dodecyl Sulfate; Staphylococcus; Time and Motion Studies | 2019 |